![Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01937-6/MediaObjects/41591_2022_1937_Fig1_HTML.png)
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine
Jason Sheltzer on Twitter: "If you choose to transfer a manuscript between Nature-family journals, you can consult a web page that lists the acceptance rates for 124 journals published by the Springer
![🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals 🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals](https://www.openacessjournal.com/assets/membership/2022032223newsr.jpg)
🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals
![Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 | Nature Communications Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-31441-x/MediaObjects/41467_2022_31441_Fig1_HTML.png)
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 | Nature Communications
![Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01772-9/MediaObjects/41591_2022_1772_Fig1_HTML.png)
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine
![Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma | Nature Medicine Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01695-5/MediaObjects/41591_2022_1695_Fig1_HTML.png)